| Market Capitalization (Millions $) |
248 |
| Shares
Outstanding (Millions) |
35 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
2 |
| Net Income (TTM) (Millions $) |
-15 |
| Cash Flow (TTM) (Millions $) |
1 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
The company is a global healthcare holding company with operations in South Korea, Switzerland, and the United States. It focuses on identifying, leading, and supporting the growth of subsidiaries engaged in pharmaceutical and medical device technologies. The company employs a hub-and-spoke business model, collaborating with academic and industry partners to develop and commercialize therapeutic product candidates, including oral T-cell immunotherapies, recombinant biologics, and neurovascular surgical devices. Its activities are supported by a substantial patent portfolio.
Company Address: 10900 NE 4th Street Bellevue 98004 WA
Company Phone Number: 635-7700 Stock Exchange / Ticker: NASDAQ BLAC
|
